Uremic patients frequently present mineral bone disorder (MBD) which is a systemic syndrome characterized by vascular calcification, abnormalities in bone turnover, vitamin D deficiency, defective metabolism of calcium and phosphate, an increase in FGF-23 and PTH levels (Duque et al., 2020). The gene discussed is PTH; the disease is Marchiafava-Bignami disease.